Screener
Eton Pharmaceuticals, Inc. ETON Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-017064
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Intangible assets, net | 43,738 | 30,878 |
| Operating lease right-of-use assets, net | 301 | 310 |
| Other long-term assets, net | 54 | 19 |
| Total assets | $97,710 | $92,114 |
| Liabilities and stockholders’ equity | ||
| Current liabilities: | ||
| Accounts payable | $13,485 | $10,976 |
| Short-term debt, net of debt discount | 11,808 | 8,789 |
Document
FAQ
- What is Eton Pharmaceuticals, Inc.'s total assets?
- Eton Pharmaceuticals, Inc. (ETON) reported total assets of $97.71M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Eton Pharmaceuticals, Inc.'s total assets increased by 16.3% year-over-year, from $84.03M to $97.71M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Eton Pharmaceuticals, Inc.'s total assets has grown at a 28.5% compound annual growth rate (CAGR), from $26.32M to $92.11M.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Eton Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude